Molecular formula: | C18H19N3O |
Average mass: | 293.370 |
Monoisotopic mass: | 293.152812 |
ChemSpider ID: | 181040 |
1 of 1 defined stereocentres
(+)-(7R)-10-Methyl-7-((5-methyl-1H-imidazol-4-yl)methyl)-8,9-dihydropyrido[1,2-a]indol-6(7H)-one
(+)-(7R)-8,9-dihydro-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]pyrido[1,2-a]indol-6(7H)-one
(+)-FK 1052
(7R)-10-Methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-on
[German]
[ACD/IUPAC Name](7R)-10-Methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one
[ACD/IUPAC Name](7R)-10-Méthyl-7-[(5-méthyl-1H-imidazol-4-yl)méthyl]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one
[French]
[ACD/IUPAC Name]129300-27-2
[RN]Fabesetron
[INN]fabesetrón
[Spanish]
[INN]fabésétron
[Latin]
[INN]fabesetronum
[Latin]
[INN]Pyrido[1,2-a]indol-6(7H)-one, 8,9-dihydro-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-, (7R)-
[ACD/Index Name]QU72HVX338
[UNII]фабесетрон
[Russian]
[INN]فابيسيترون
[Arabic]
[INN]法贝司琼
[Chinese]
[INN](+)-(R)-8,9-dihydro-10-methyl-7-((5-methylimidazol-4-yl)methyl)pyrido[1,2-a]indol-6(7H)-one
(7R)-10-METHYL-7-[(5-METHYL-1H-IMIDAZOL-4-YL)METHYL]-6H,7H,8H,9H-PYRIDO[1,2-A]INDOL-6-ONE
(7R)-10-METHYL-7-[(5-METHYL-1H-IMIDAZOL-4-YL)METHYL]-7H,8H,9H-PYRIDO[1,2-A]INDOL-6-ONE
(7R)-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydro-7H-pyrido[1,2-a]indol-6-one
(7R)-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydro-7H-pyrido[1,6-a]indol-6-one
fabésétron
fabesetrón
fabesetron; fabesetronum
fabesetronum
фабесетрон
فابيسيترون
法贝司琼